The ligand binding region of the sigma-1 receptor: Studies utilizing photoaffinity probes, sphingosine and N-alkylamines

Current Pharmaceutical Design

Volumn 18, Issue 7, 2012, Pages 920-929

  Ruoho, Arnold E ^a   Chu, Uyen B ^a   Ramachandran, Subramaniam ^b   Fontanilla, Dominique ^c   Mavlyutov, Timur ^a   Hajipour, Abdol R ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d ISFAHAN UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Ligand binding region; N alkylamines; Photoaffinity labeling; Shingosine; Sigma 1 receptor

Indexed keywords

ALIPHATIC AMINE; EMOPAMIL; ERGOSTEROL; FUNGAL ENZYME; HALOPERIDOL; ISOMERASE; PENTAZOCINE; SIGMA 1 OPIATE RECEPTOR; SPHINGOSINE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; DRUG BINDING SITE; DRUG STRUCTURE; ENZYME SYNTHESIS; HUMAN; HYDROPHOBICITY; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; MUTAGENESIS; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEROID BINDING; STRUCTURE ACTIVITY RELATION;

ALKANES; AMINES; BINDING SITES; HUMANS; PHOTOAFFINITY LABELS; RECEPTORS, SIGMA; SPHINGOSINE;

EID: 84857132074     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799436584     Document Type: Article

References (40)

1. Hanner M, Moebius FF, Flandorfer A, et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 1996; 93: 8072-7.
2. Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 1996; 229: 553-8.
3. Seth P, Fei YJ, Li HW, Huang W, Leibach FH, Ganapathy V. Cloning and functional characterization of a sigma receptor from rat brain. J Neurochem 1998; 70: 922-31.
4. Seth P, Leibach FH, Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem Biophys Res Commun 1997; 241: 535-40.
5. Silve S, Dupuy PH, Labit-Lebouteiller C, et al. Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits delta8-delta7 sterol isomerase activity in yeast. J Biol Chem 1996; 271: 22434-40.
6. Moebius FF, Striessnig J, Glossmann H. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol Sci 1997; 18: 67-70.
7. Aydar E, Palmer CP, Klyachko VA, Jackson MB. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 2002; 34: 399-410.
8. Hayashi T, Su TP. Sigma-1 receptor chaperones at the ERmitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 2007; 131: 596-610.
9. Keon JP, James CS, Court S, et al. Isolation of the ERG2 gene, encoding sterol delta 8->delta 7 isomerase, from the rice blast fungus Magnaporthe grisea and its expression in the maize smut pathogen Ustilago maydis. Curr Genet 1994; 25: 531-7.
10. Pal A, Hajipour AR, Fontanilla D, et al. Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe. Mol Pharmacol 2007; 72: 921-33.
11. Yamamoto H, Miura R, Yamamoto T, et al. Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding. FEBS Lett 1999; 445: 19-22.
12. Ganapathy ME, Prasad PD, Huang W, Seth P, Leibach FH, Ganapathy V. Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line. J Pharmacol Exp Ther 1999; 289: 251-60.
13. Seth P, Ganapathy ME, Conway SJ, et al. Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor. Biochim Biophys Acta 2001; 1540: 59-67.
14. Palmer CP, Mahen R, Schnell E, Djamgoz MB, Aydar E. Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res 2007; 67: 11166-75.
15. Chen Y, Hajipour AR, Sievert MK, Arbabian M, Ruoho AE. Characterization of the cocaine binding site on the sigma-1 receptor. Biochemistry 2007; 46: 3532-42.
16. Ramachandran S, Lu H, Prabhu U, Ruoho AE. Purification and characterization of the guinea pig sigma-1 receptor functionally expressed in Escherichia coli. Protein Expr Purif 2007; 51: 283-92.
17. Fontanilla D, Hajipour AR, Pal A, Chu UB, Arbabian M, Ruoho AE. Probing the steroid binding domain-like I (SBDLI) of the sigma-1 receptor binding site using N-substituted photoaffinity labels. Biochemistry 2008; 47: 7205-17.
18. Pal A, Chu UB, Ramachandran S, et al. Juxtaposition of the Steroid Binding Domain-like I and II Regions Constitutes a Ligand Binding Site in the {sigma}-1 Receptor. J Biol Chem 2008; 283: 19646-56.
19. Hayashi T, Su TP. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther 2003; 306: 718-25.
20. Mavlyutov TA, Ruoho AE. Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 cells. J Mol Signal 2007; 2: 8.
21. Hayashi T, Su TP. Sigma-1 receptors at galactosylceramideenriched lipid microdomains regulate oligodendrocyte differentiation. Proc Natl Acad Sci USA 2004; 101: 14949-54.
22. Gebreselassie D, Bowen WD. Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes. Eur J Pharmacol 2004; 493: 19-28.
23. Crawford KW, Bowen WD. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res 2002; 62: 313-22.
24. Kumagai K, Shono K, Nakayama H, Ohno Y, Saji I. (2R-trans)-2-butyl-5-heptylpyrrolidine as a potent sigma receptor ligand produced by Streptomyces longispororuber. J Antibiot (Tokyo) 2000; 53: 467-73.
25. Ramachandran S, Chu UB, Mavlyutov TA, Pal A, Pyne S, Ruoho AE. The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. Eur J Pharmacol 2009; 609: 19-26.
26. Moebius FF, Reiter RJ, Hanner M, Glossmann H. High affinity of sigma 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase. Br J Pharmacol 1997; 121: 1-6.
27. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008; 9: 139-50.
28. Spiegel S, Milstien S. Functions of the multifaceted family of sphingosine kinases and some close relatives. J Biol Chem 2007; 282: 2125-9.
29. Urs AN, Dammer E, Sewer MB. Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. Endocrinology 2006; 147: 5249-58.
30. Urs AN, Dammer E, Kelly S, Wang E, Merrill AH, Jr., Sewer MB. Steroidogenic factor-1 is a sphingolipid binding protein. Mol Cell Endocrinol 2007; 265-266: 174-8.
31. Sullards MC, Merrill AH, Jr. Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Sci STKE 2001; 2001: p11.
32. Edsall LC, Spiegel S. Enzymatic measurement of sphingosine 1-phosphate. Anal Biochem 1999; 272: 80-6.
33. Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 2009; 323: 934-7.
34. Chu UB, Hajipour AR, Ramachandran S, Ruoho AE. Characterization of 4-Nitrophenylpropyl-N-alkylamine Interactions with Sigma Receptors. Biochemistry 2011.
35. Ablordeppey SY, Fischer JB, Glennon RA. Is a nitrogen atom an important pharmacophoric element in sigma ligand binding? Bioorg Med Chem 2000; 8: 2105-11.
36. Xu J, Chu W, Tu Z, Jones LA, Luedtke RR, Perlmutter JS, Mintun MA, Mach RH. [(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization. Synapse 2009; 63: 717-28.
37. Glennon RA. Pharmacophore identification for sigma-1 (sigma1) receptor binding: application of the "deconstruction-reconstructionelaboration" approach. Mini Rev Med Chem 2005; 5: 927-40.
38. Maeda DY, Williams W, Kim WE, Thatcher LN, Bowen WD, Coop A. N-arylalkylpiperidines as high-affinity sigma-1 and sigma-2 receptor ligands: phenylpropylamines as potential leads for selective sigma-2 agents. Bioorg Med Chem Lett 2002; 12: 497-500.
39. Mesangeau C, Narayanan S, Green AM, et al. Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity. J Med Chem 2008; 51: 1482-6.
40. Pal A, Chu UB, Ramachandran S, et al. Juxtaposition of the steroid binding domain-like I and II regions constitutes a ligand binding site in the sigma-1 receptor. J Biol Chem 2008; 283: 19646-56.